Clinical trial of modulatory effects of oxytocin treatment on higher-order social cognition in autism spectrum disorder: a randomized, placebo-controlled, double-blind and crossover trial.
Katrin PreckelPhilipp KanskeTania SingerFrieder M PaulusSören KrachPublished in: BMC psychiatry (2016)
German Clinical Trial Register DRKS00010053 . The trial was registered on the 8th of April 2016.
Keyphrases
- double blind
- placebo controlled
- clinical trial
- phase iii
- phase ii
- study protocol
- autism spectrum disorder
- open label
- phase ii study
- healthcare
- randomized controlled trial
- mild cognitive impairment
- multiple sclerosis
- squamous cell carcinoma
- intellectual disability
- radiation therapy
- combination therapy
- replacement therapy